[{"NetIncomeLoss_1_Q2_USD":-33663000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":66282000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_0_Q2_USD":200300000.0,"RepaymentsOfLongTermDebt_2_Q2_USD":7250000.0,"InterestAndOtherIncome_2_Q2_USD":600000.0,"InterestAndOtherIncome_1_Q2_USD":290000.0,"PaidInKindInterest_2_Q2_USD":399000.0,"OperatingLeasesRentExpenseNet_2_Q2_USD":1000000.0,"OperatingLeasesRentExpenseNet_1_Q2_USD":500000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-393000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-223441000.0,"Depreciation_2_Q2_USD":232000.0,"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q2_USD":21290000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":1558000.0,"AssetsCurrent_0_Q2_USD":573632000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":7002000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":7002000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":2080000.0,"CommonStockSharesIssued_0_Q2_shares":66296000.0,"Assets_0_Q2_USD":584891000.0,"OtherComprehensiveIncomeLossNetOfTax_2_Q2_USD":-439000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":-311000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":66250000.0,"ShareBasedCompensation_2_Q2_USD":11068000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":12573000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"IncreaseDecreaseInOtherNoncurrentAssets_2_Q2_USD":1178000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":41398000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":21074000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":7414000.0,"GainsLossesOnExtinguishmentOfDebt_2_Q2_USD":-212000.0,"CommonStockValue_0_Q2_USD":7000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_Q2_USD":-2688000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":-6487000.0,"InterestAndDebtExpense_2_Q2_USD":414000.0,"InterestAndDebtExpense_1_Q2_USD":306000.0,"RestrictedCash_0_Q2_USD":210000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_2_Q2_USD":129969000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-64796000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-33974000.0,"OtherAssetsNoncurrent_0_Q2_USD":3306000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":38974000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":4755000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":925796000.0,"Liabilities_0_Q2_USD":26340000.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_2_Q2_USD":-100000.0,"OperatingLeaseLiability_0_Q2_USD":6736000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":23145000.0,"ShareBasedCompensation_1_Q2_USD":5993000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":5443000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"PaymentsToAcquireMarketableSecurities_2_Q2_USD":353088000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":518000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":5993000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2_Q2_USD":11068000.0,"AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1_0_Q2_security":20.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-56591000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0_Q2_USD":282500000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":2032000.0,"LiabilitiesCurrent_0_Q2_USD":21290000.0,"AccountsPayableCurrent_0_Q2_USD":2404000.0,"NonoperatingIncomeExpense_2_Q2_USD":186000.0,"NonoperatingIncomeExpense_1_Q2_USD":-16000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":39184000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":6138000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":1660000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.055,"PaymentsOfDebtExtinguishmentCosts_2_Q2_USD":611000.0,"OperatingLeasePayments_2_Q2_USD":1100000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":2300000.0,"NetIncomeLoss_2_Q2_USD":-64357000.0,"RestrictedCashNoncurrent_0_Q2_USD":210000.0,"CommonStockSharesOutstanding_0_Q2_shares":66296000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-286519000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-366859000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":678000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":722000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":2166000.0,"CommonStockSharesAuthorized_0_Q2_shares":200000000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q2_USD":528520000.0,"PreferredStockValue_0_Q2_USD":null,"LiabilitiesAndStockholdersEquity_0_Q2_USD":584891000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":5303000.0,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":1022000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":2818000.0,"OperatingExpenses_2_Q2_USD":64543000.0,"OperatingExpenses_1_Q2_USD":33647000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2_Q2_USD":0.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-0.97,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.51,"OtherLiabilitiesNoncurrent_0_Q2_USD":295000.0,"StockholdersEquity_0_Q2_USD":558551000.0,"DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_0_Q2_USD":0.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":322000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":-1987000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":1981000.0,"DebtSecuritiesAvailableForSaleAllowanceForCreditLossWriteoff_2_Q2_USD":0.0,"Ticker":"KURA","CIK":"1422143","name":"KURA ONCOLOGY, INC.","OfficialName":"Kura Oncology Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"1071823749.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20210805"}]